Boehringer Ingelheim Pharmaceuticals

Highly Engaged Employees

Boehringer Ingelheim USA Corporation, founded in 1971, is a prominent entity within the Pharmaceuticals and Healthcare sectors. The company is dedicated to advancing human and animal health through rigorous research and development, focusing on delivering innovative medicines and comprehensive healthcare solutions. Its commitment to scientific discovery drives the creation of cutting-edge treatments for a wide spectrum of medical needs, positioning it as a key player in biopharmaceutical innovation. The company's operational footprint includes a significant presence in the United States, contributing to global health advancements.

Operating with a workforce of 1,000 to 5,000 employees across 3 locations, Boehringer Ingelheim USA maintains its headquarters in Ridgefield, Connecticut. This established presence underscores its commitment to localized operations while contributing to a global network. The company's product portfolio encompasses pharmaceuticals, with a particular emphasis on areas like oncology and respiratory medicine, aiming to address critical diseases. For insights into the people driving these innovations, you can Meet Boehringer Ingelheim's team.

Boehringer Ingelheim USA's strategic focus on research-driven pharmaceutical development is evident in its pursuit of novel therapies and medical advancements. The company's revenue reached $271.6M, reflecting its substantial market impact and capacity for investment in R&D. By prioritizing patient outcomes and therapeutic innovation, Boehringer Ingelheim USA continues to shape the future of healthcare, offering vital solutions that improve quality of life for both humans and animals.